AI assistant
Sun Pharmaceutical Industries Ltd. Earnings Release 2021
59215_rns_2020-07-23_5c5b9ba7-ac7c-4f26-91d8-d9e734062fda.pdf
Earnings Release
Open in viewerOpens in your device viewer
Sun Pharmaceutical Industries Ltd., SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 CIN: L24230GJ1993PLC019050 www.sunpharma.com
23 July 2020.
National Stock Exchange of India Ltd, Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051.
BSE Limited, Market Operations Dept. Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001.
Dear Sirs,
Sub: Press Release
We are pleased to enclose herewith our Press Release relating to announcement of financial results for the first quarter ending June 30, 2020, which we shall be releasing after sending this letter to you. This is for your information and record.
Thanking you,
Yours faithfully, For Sun Pharmaceutical Industries Ltd
Ashok I. Bhuta Compliance Officer
Encl: as above
Sun Pharmaceutical Industries Ltd. SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 CIN: L24230GJ1993PLC019050 www.sunpharma.com
FOR IMMEDIATE RELEASE
Sun Pharma to announce first quarter results on July 31, 2020
July 23, 2020, Mumbai: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) will announce results for the first quarter ending June 30, 2020 on July 31, 2020. These results will also be available on the Company website, www.sunpharma.com.
Earnings call (06.30 pm IST, July 31, 2020)
The Company will conduct an hour long call at 06.30 pm IST on July 31, 2020 where senior management will discuss the Company's performance and answer questions from participants. To participate in this conference call, please dial the numbers provided below, five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.sunpharma.com. A transcript of this conference call will also be available on the website.
Summary of events
| Event | Date and time | Telephone number/ website |
|---|---|---|
| Earnings release | July31, 2020 | www.sunpharma.com |
| Earnings conference call | 06.30pm IST,July31,2020 | UniversalNumber:+91 22 50641325 |
| Via audio webcast, details of which willbe made available onwww.sunpharma.com | ||
| Pre‐registrationdetails(toavoidwaittime) | Click here toDiamondPassRegistration | |
| Replay of conference call | July31, 2020toAugust07, 2020 | India: +91 22 71945757India: +91 22 66635757 |
| Code: 82390 | ||
| Via audio webcast playback, details ofwhich will be madeavailable onwww.sunpharma.com |
Sun Pharmaceutical Industries Ltd. SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 CIN: L24230GJ1993PLC019050 www.sunpharma.com
Disclaimer:
Statements in this "Document" describing the Company's objectives, projections, estimates, expectations, plans or predictions or industry conditions or events may be "forward looking statements" within the meaning of applicable securities laws and regulations. Actual results, performance or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof.
About Sun Pharmaceutical Industries Ltd. (CIN - L24230GJ1993PLC019050):
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in over 100 countries across the world, at affordable prices. Its global presence is supported by manufacturing facilities spread across 6 continents and approved by multiple regulatory agencies, coupled with a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities across multiple R&D centers, with investments of approximately 6% of annual revenues in R&D. For further information, please visit www.sunpharma.com & follow us on Twitter @SunPharma_Live
Contacts:
Investors: Media: Nimish Desai Gaurav Chugh Tel +91 22 4324 4324, Xtn 2778 Tel +91 22 4324 4324, Xtn 5373 Tel Direct +91 22 4324 2778 Tel Direct +91 22 4324 5373 Mobile +91-98203 30182 Mobile +91 98104 71414
E mail [email protected] E mail [email protected]